Clinical Trial Update: Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating dose-intensified hypofractionated radiotherapy with an IGRT-mediated boost for spinal metastases, focusing on efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Metastases

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Spinal Metastases | Phase 2 | Status: UNKNOWN